Topical nasal steroid for management of adenoid hypertrophy in children

Abstract

Background: Adenoid hypertrophy is a common issue observed in childhood, with an estimated prevalence of 34.46% in children. This study aimed to objectively assess the impact of the topical nasal steroid Mometasone furoate on adenoidal hypertrophy in children. Methods: This observational prospective study was done on 106 patients aged from 4 to 8 years old, both sexes, presented with nasal obstructive symptoms and diagnosed with adenoid hypertrophy based on lateral x-ray nasopharynx with A/N ratio >0.73 using Fujioka method. Results: A/N ratio before intervention with Mean ± SD = 0.78±0.45, while after intervention with Mean ± SD= 0.70±0.47, with high significance between 2 measurements. There was no impact of sex and age on intervention efficacy in A/N ratio reduction after and before intervention. SNOT22 score before intervention was reduced after intervention with high significance (p